Karyopharm Therapeutics
KPTI
KPTI
108 hedge funds and large institutions have $300M invested in Karyopharm Therapeutics in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 42 increasing their positions, 21 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
27% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 26
38% less capital invested
Capital invested by funds: $482M → $300M (-$182M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
108
Holding in Top 10
–
Calls
$4.08M
Puts
$1.3M
Top Buyers
| 1 | +$13.3M | |
| 2 | +$9M | |
| 3 | +$5.17M | |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$3.37M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$3.02M |
Top Sellers
| 1 | -$14.4M | |
| 2 | -$10.3M | |
| 3 | -$9.11M | |
| 4 |
DM
Deerfield Management
New York
|
-$4.45M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.99M |